Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1549 participants.

Also called NCT01167881

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,549 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01167881
  • EudraCT 2009-016244-39
Other papers using this trial's data
  • Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial The lancet. Diabetes & endocrinology, 2014-09 DOI, PubMed 24948511

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Austria, Canada, Colombia, Czechia, Finland, Hong Kong SAR China, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01167881. Randomized; double masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2014-08-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
BI 10773
Intervention (Drug)
Glimepiride
Intervention (Drug)
Placebo
Intervention (Drug)
Placebo
Lead sponsor
Boehringer Ingelheim (class: industry)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01167881
Content hash
11bd835bf1bef42cf7864452ce830cc5b89840f0fa4375b1f685ffa896d2f1c6